New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 25, 2014
10:00 EDTRGDO, ITMN, THOR, HNI, SNP, STLD, FLOn The Fly: Analyst Downgrade Summary
Foot Locker (FL) downgraded to Neutral from Overweight at Piper Jaffray... HNI Corporation (HNI) downgraded to Market Perform from Outperform at Raymond James... InterMune (ITMN) downgraded to Hold from Buy at Stifel... Steel Dynamics (STLD) downgraded to Neutral from Outperform at Credit Suisse... Thoratec (THOR) downgraded to Neutral from Overweight at Piper Jaffray... Regado Biosciences (RGDO) downgraded to Hold from Buy at Deutsche Bank... Sinopec (SNP) downgraded to Neutral from Buy at Citigroup.
News For FL;HNI;ITMN;STLD;THOR;RGDO;SNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
07:58 EDTTHORThoratec to hold an investor and analyst meeting
Subscribe for More Information
05:35 EDTTHORThoratec announces positive results from ROADMAP study
Thoratec announced results from the ROADMAP Study, or the Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients. For the primary endpoint, a composite of survival and functional improvement, ROADMAP demonstrated a statistically significant benefit of HeartMate II LVAD support relative to optimal medical management in ambulatory NYHA Class IIIB/IV heart failure patients. Survival in the HeartMate II group was 80% at one year, compared with 64% for medically managed patients on an as-treated basis. At one year of follow-up, 39% of patients within the HeartMate II group met the primary endpoint of survival on the original therapy along with a 75 meter increase in six minute walk test distance, compared with 21% of patients on optimal medical management, representing a statistically significant difference.
April 16, 2015
10:04 EDTTHORHigh option volume stocks
Subscribe for More Information
09:52 EDTTHORThoratec comments on HeartMate II data in ENDURANCE therapy trial
Subscribe for More Information
08:53 EDTTHORBofA/Merrill medical technology analysts hold analyst/industry conference call
Subscribe for More Information
April 15, 2015
10:46 EDTSTLDBofA/Merrill metals/mining/steel analysts hold analyst/industry conference call
Subscribe for More Information
April 14, 2015
10:03 EDTTHORThoratec management to meet with Oppenheimer
Subscribe for More Information
April 11, 2015
14:10 EDTTHORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
April 10, 2015
08:37 EDTTHORThoratec price target raised to $50 from $45 at Leerink
Subscribe for More Information
April 9, 2015
09:18 EDTFLBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
08:24 EDTSNPSinopec volatility flat on wide price movement
Subscribe for More Information
April 7, 2015
10:48 EDTTHORLeerink medical supplies & devices analyst has analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use